top of page

Rajesh Exports Shares Hit Lower Circuit for Third Straight Session Amid Sebi Probe

Shares of Rajesh Exports fell 5% and hit the lower circuit limit for the third consecutive trading session as investors reacted to Sebi's allegations regarding fund diversion, inadequate disclosures, and alleged financial irregularities. The company has denied the allegations and said it will resubmit documents to the market regulator to clarify the issues raised in the interim order.

By Finblage Editorial Desk

5:15 pm

8 June 2026

Shares of Rajesh Exports remained under heavy selling pressure on Monday, hitting the 5% lower circuit limit for the third consecutive trading session following Sebi's interim order alleging financial irregularities and diversion of company funds through promoter-linked entities and personal accounts.


The stock was locked at its lower circuit limit of ₹94.50, down ₹4.95 or 4.98%, extending losses after details of the regulator's investigation became public.


The Securities and Exchange Board of India (Sebi), in its interim order dated June 3, alleged that Rajesh Exports had inflated its financial figures and routed company funds through entities linked to promoters without adequate disclosures. The regulator also raised concerns regarding corporate governance practices and compliance with listing regulations.


According to the order, Sebi alleged revenue inflation amounting to approximately ₹15.15 lakh crore during the period from FY21 to FY25. The regulator is currently examining the company's financial records and related-party transactions as part of the ongoing investigation.


Responding to the allegations, Rajesh Exports stated that it had already submitted between 300 GB and 400 GB of documents to Sebi and believes the regulator may not have identified the relevant records within the large volume of data provided. The company said it would resubmit all requested documents within the next 15 days.


Founder and Chairman Rajesh Mehta strongly disputed the regulator's findings, claiming that Sebi had incorrectly interpreted financial data. According to Mehta, the alleged inflation figure resulted from confusion between EBITDA and revenue figures.


He stated that EBITDA represents gross profit and alleged that the regulator had mistakenly treated gross profit figures as revenue, leading to what he described as a significant error in the calculation. The company maintains that its financial statements accurately reflect its business operations and that the allegations will be clarified through the submission of additional documentation.


Meanwhile, Sebi Chairman Tuhin Kanta Pandey declined to comment on the merits of the ongoing case, stating that individual matters under investigation are subject to a quasi-judicial process and must proceed according to the legal framework established by the regulator.


The case remains under regulatory review, and market participants are closely monitoring developments given the seriousness of the allegations and their potential impact on investor confidence and corporate governance standards.

Sources & Disclaimer

This article is compiled from publicly available information, including company disclosures, stock exchange filings, regulatory announcements, and reports from global and domestic financial publications. The content has been editorially reviewed and enhanced by the Finblage Editorial Desk for clarity and investor awareness purposes only.

All information provided on Finblage is strictly for educational and informational use and should not be considered as financial, investment, legal, or professional advice. Readers are advised to conduct their own independent research and consult a certified financial advisor before making any investment decisions. Finblage shall not be held responsible for any losses arising from the use of information published on this website.

Premium Edition

Copilot_20260121_132432.png
crown.png

Sector > FMCG

Pricing Power on Trial : India's FMCG Majors Reach for the Lever Again in Q2 FY27

India’s FMCG sector is entering another pricing cycle as crude and palm-oil inflation pressures margins. Major players are opting for calibrated price hikes and shrinkflation to protect affordability while recovering costs. Despite these pressures, Q1 FY27 delivered resilient, volume-led growth, indicating healthy underlying demand.

11 August 2026

Continue

Latest Market Insights

India Core Sector Growth Remains Healthy Despite July Moderation

21 August 2026

India Unemployment Rate Falls to Four Month Low in July 2026

18 August 2026

Independence Day 2026 Policy Roadmap and the Investment Themes Shaping Viksit Bharat 2047

15 August 2026

Merger & Acquisition

Yatharth Hospital Expands Delhi NCR Presence Through Gurugram Hospital Asset Acquisition

14 May 2026

Sun Pharma Acquisition of Organon Strategic Expansion and Global Positioning Shift

28 April 2026

Varun Beverages Expands Beyond Soft Drinks with ₹131 Crore South Africa Dairy Acquisition

18 March 2026

whatsapp-call-icon-psd-editable_314999-3

Whatsapp Channel

Want stock insights, market trends, and exclusive research updates in real-time? Don’t miss out – Finblage is now on WhatsApp!

bottom of page